XML 18 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 555 $ 232
Accounts receivable - net of allowance for doubtful accounts of $4 and $5, respectively 356 363
Inventories 276 224
Other current assets 63 47
Total Current Assets 1,250 866
Property, plant and equipment, net 774 763
Intangible assets, net 833 878
Goodwill 2,076 2,075
Marketable securities 20 22
Other non-current assets 72 67
TOTAL ASSETS 5,025 4,671
Current Liabilities    
Accounts payable 210 195
Product warranty liability 32 33
Current portion of long-term debt 6 6
Deferred revenue 41 38
Other current liabilities 212 208
Total Current Liabilities 501 480
Product warranty liability 27 24
Deferred revenue 89 93
Long-term debt 2,497 2,501
Deferred income taxes 519 536
Other non-current liabilities 159 163
TOTAL LIABILITIES 3,792 3,797
Commitments and Contingencies (see Note 18)
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.01 par value, 100,000,000 shares authorized, none issued and outstanding 0 0
Paid in capital 1,891 1,848
Accumulated deficit (628) (953)
Accumulated other comprehensive loss, net of tax (31) (22)
TOTAL STOCKHOLDERS’ EQUITY 1,233 874
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY 5,025 4,671
Voting Common Stock    
STOCKHOLDERS’ EQUITY    
Common stock 1 1
Non-voting Common Stock    
STOCKHOLDERS’ EQUITY    
Common stock $ 0 $ 0